Literature DB >> 21358791

Another bitter pill: a case of toxicity from DMAA party pills.

Paul Gee, Suzanne Jackson, Josie Easton.   

Abstract

"Party pills" continue to be legally sold though the main ingredient is no longer 1-benzylpiperazine. Dimethylamylamine (DMAA) is a synthetic stimulant and is one of the main ingredients of new "BZP-free party pills". Though patented in the 1950s as a nasal decongestant, little is known of its pharmacology via the ingested route. This case report describes a 21-year-old male who suffered a cerebral haemorrhage shortly after ingesting two capsules of DMAA.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21358791

Source DB:  PubMed          Journal:  N Z Med J        ISSN： 0028-8446


  6 in total

1.  Abuse liability of the dietary supplement dimethylamylamine.

Authors:  Sean B Dolan; Michael B Gatch
Journal:  Drug Alcohol Depend       Date:  2014-11-25       Impact factor: 4.492

2.  Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium.

Authors:  Triston B Smith; Brian A Staub; Gayathri M Natarajan; David M Lasorda; Indu G Poornima
Journal:  Tex Heart Inst J       Date:  2014-02

Review 3.  Adverse Effects of Nutraceuticals and Dietary Supplements.

Authors:  Martin J J Ronis; Kim B Pedersen; James Watt
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

4.  Effects of controlled doses of Oxyelite Pro on physical performance in rats.

Authors:  Paulo Vinicios Camuzi Zovico; Victor Magalhães Curty; Marcos André Soares Leal; Eduardo Frizzera Meira; Daniel Ventura Dias; Lívia Carla de Melo Rodrigues; Silvana Dos Santos Meyrelles; Edilamar Menezes De Oliveira; Paula Frizera Vassallo; Valério Garrone Barauna
Journal:  Nutr Metab (Lond)       Date:  2016-12-06       Impact factor: 4.169

Review 5.  Analytical Challenges and Metrological Approaches to Ensuring Dietary Supplement Quality: International Perspectives.

Authors:  Alessandra Durazzo; Barbara C Sorkin; Massimo Lucarini; Pavel A Gusev; Adam J Kuszak; Cindy Crawford; Courtney Boyd; Patricia A Deuster; Leila G Saldanha; Bill J Gurley; Pamela R Pehrsson; James M Harnly; Aida Turrini; Karen W Andrews; Andrea T Lindsey; Michael Heinrich; Johanna T Dwyer
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

6.  Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men.

Authors:  Brian K Schilling; Kelley G Hammond; Richard J Bloomer; Chaela S Presley; Charles R Yates
Journal:  BMC Pharmacol Toxicol       Date:  2013-10-04       Impact factor: 2.483
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.